Construction of the new Hillsboro Hops ballpark reached a major milestone with the "topping out" of its highest point on Friday.

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment ...

Genentech has secured a second marketed stroke therapy after the US Food and Drug Administration (FDA) approved a label expansion for clot-dissolving agent TNKase (tenecteplase) – the first ...

Construction of the $120 million project, with oversight by design-build contractor Mortenson, has proceeded apace without ...

(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health (NIH)-sponsored Phase III OUtMATCH study ...

HILLSBORO, Ore. (KPTV) - The City of Hillsboro broke ground Monday on its first year-round adult permanent housing shelter. Seventy-five beds are slotted for the site. That includes 35 indoor ...

Finance and more. For most households in Hillsboro, CNET found that HiLight is the best internet service provider. This fiber network is owned and operated by the city -- which means it can offer ...

The hub has also been created to strengthen an existing relationship between Harvard and Roche that has been in place for over a decade.

Genentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.

Basel, March 7, 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY), announced today the launch of the Roche Genentech Innovation Center Boston at Harvard’s Enterprise Research Campus in Allston which ...